Interestingly, by testing a library of shRNA constructed against 1000 human proteins, it was possible to identify the inhibition of GSK3α over GSK3β as the principal cause for the effects observed on AML cells [43]. The gene discussed is GSK3A; the disease is acute myeloid leukemia.